Please use this identifier to cite or link to this item:
https://hdl.handle.net/11499/47490
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Sengöz T. | - |
dc.contributor.author | Karakaya Y.A. | - |
dc.contributor.author | Gültekin A. | - |
dc.contributor.author | Yaylali O. | - |
dc.contributor.author | Senol H. | - |
dc.contributor.author | Yuksel D. | - |
dc.date.accessioned | 2023-01-09T21:25:00Z | - |
dc.date.available | 2023-01-09T21:25:00Z | - |
dc.date.issued | 2022 | - |
dc.identifier.issn | 2253-654X | - |
dc.identifier.uri | https://doi.org/10.1016/j.remn.2020.11.006 | - |
dc.identifier.uri | https://hdl.handle.net/11499/47490 | - |
dc.description.abstract | Objectives: In this study, we aimed to investigate the correlation between SUVmax of primary tumor and prognostic factors/molecular subtype in ductal breast cancer patients. Materials and methods: We retrospectively reviewed 150 female patients with pathologically proven invasive ductal breast cancer from January 2015 to October 2019 who underwent 18F-FDG PET/CT for initial staging. Histopathological prognostic features of the primary tumor (histological grade, hormone receptor status, Ki-67 index, vb.) were obtained from the tru-cut biopsy report. In 18F-FDG PET/CT studies, the maximum standardized uptake value (SUVmax) of the primary breast tumor was calculated and compared with the presence of axillary lymphadenopathy and/or distant metastases, histopathological prognostic factors and molecular subtype. Results: The high SUVmax of primary breast tumors is significantly correlated with the clinicopathological factors: high tumor size, high histologic grade, high Ki-67 index, axillary lymph node positivity and distant metastasis. SUVmax value was significantly higher in patients with basal subtype than patients with Luminal A subtype (8.14 ± 3.71 and 4.64 ± 2.45, p = 0.002). Correlation analysis revealed a low correlation between Ki-67 index and SUVmax (r = 0.276, p = 0.001) and moderate correlation between tumor size and SUVmax (r = 0.470, p = 0.001). In multivariate linear regression analysis, Ki-67 index and tumor size had a statistically significant effect on SUVmax values. As these parameters increase, it is seen that it increases SUVmax values (p = 0.004, Std Beta: 0.228, 95% CI: 0.010–0.055 and p = 0.001, Std Beta: 0.374, 95% CI: 0.55–0.136, respectively). Conclusión: High SUVmax value is associated with prognotic factors suggesting poor prognosis. Pretreatment 18F-FDG PET/CT can be used as a tool to predict prognosis in breast cancer. © 2021 Sociedad Española de Medicina Nuclear e Imagen Molecular | en_US |
dc.language.iso | en | en_US |
dc.publisher | Ediciones Doyma, S.L. | en_US |
dc.relation.ispartof | Revista Espanola de Medicina Nuclear e Imagen Molecular | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | 18F-FDG | en_US |
dc.subject | Ductal breast cancer | en_US |
dc.subject | Molecular subtype | en_US |
dc.subject | p53 | en_US |
dc.subject | SUVmax | en_US |
dc.subject | fluorodeoxyglucose f 18 | en_US |
dc.subject | hormone receptor | en_US |
dc.subject | Ki 67 antigen | en_US |
dc.subject | Article | en_US |
dc.subject | axillary lymph node | en_US |
dc.subject | axillary lymphadenopathy | en_US |
dc.subject | basal subtype breast cancer | en_US |
dc.subject | breast cancer | en_US |
dc.subject | breast cancer molecular subtype | en_US |
dc.subject | cancer grading | en_US |
dc.subject | cancer patient | en_US |
dc.subject | cancer prognosis | en_US |
dc.subject | cancer staging | en_US |
dc.subject | correlational study | en_US |
dc.subject | distant metastasis | en_US |
dc.subject | female | en_US |
dc.subject | histopathology | en_US |
dc.subject | human | en_US |
dc.subject | invasive ductal breast carcinoma | en_US |
dc.subject | luminal A breast cancer | en_US |
dc.subject | lymphadenopathy | en_US |
dc.subject | major clinical study | en_US |
dc.subject | maximum standardized uptake value | en_US |
dc.subject | positron emission tomography-computed tomography | en_US |
dc.subject | prediction | en_US |
dc.subject | primary tumor | en_US |
dc.subject | retrospective study | en_US |
dc.subject | tumor volume | en_US |
dc.subject | breast tumor | en_US |
dc.subject | diagnostic imaging | en_US |
dc.subject | prognosis | en_US |
dc.subject | Breast Neoplasms | en_US |
dc.subject | Female | en_US |
dc.subject | Fluorodeoxyglucose F18 | en_US |
dc.subject | Humans | en_US |
dc.subject | Positron Emission Tomography Computed Tomography | en_US |
dc.subject | Prognosis | en_US |
dc.subject | Retrospective Studies | en_US |
dc.title | Relationships of 18F-FDG uptake by primary tumors with prognostic factors and molecular subtype in ductal breast cancer | en_US |
dc.title.alternative | Correlación entre la captación de 18F-FDG del tumor primario con los factores pronósticos y subtipo molecular del cáncer ductal de mama | en_US |
dc.type | Article | en_US |
dc.identifier.volume | 41 | en_US |
dc.identifier.issue | 1 | en_US |
dc.identifier.startpage | 32 | en_US |
dc.identifier.endpage | 38 | en_US |
dc.identifier.doi | 10.1016/j.remn.2020.11.006 | - |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.authorscopusid | 56667569600 | - |
dc.authorscopusid | 56464098200 | - |
dc.authorscopusid | 57213854346 | - |
dc.authorscopusid | 23135840600 | - |
dc.authorscopusid | 56345836900 | - |
dc.authorscopusid | 6701446280 | - |
dc.identifier.pmid | 34991834 | en_US |
dc.identifier.scopus | 2-s2.0-85123270219 | en_US |
dc.identifier.wos | WOS:000741424000005 | en_US |
dc.identifier.scopusquality | Q3 | - |
item.languageiso639-1 | en | - |
item.fulltext | No Fulltext | - |
item.openairetype | Article | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.01. Surgical Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
crisitem.author.dept | 14.02. Internal Medicine | - |
Appears in Collections: | PubMed İndeksli Yayınlar Koleksiyonu / PubMed Indexed Publications Collection Scopus İndeksli Yayınlar Koleksiyonu / Scopus Indexed Publications Collection Tıp Fakültesi Koleksiyonu WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection |
CORE Recommender
SCOPUSTM
Citations
2
checked on Oct 13, 2024
WEB OF SCIENCETM
Citations
2
checked on Oct 22, 2024
Page view(s)
52
checked on Aug 24, 2024
Google ScholarTM
Check
Altmetric
Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.